9 -Tetrahydrocannabinol in depressed patients.
D000284:Administration, Oral; D000328:Adult; D000339:Affect / Q000187:drug effects; D000342:Affective Symptoms / Q000139:chemically induced; D001007:Anxiety; D001828:Body Image / Q000187:drug effects; D002188:Cannabis / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003861:Depersonalization / Q000139:chemically induced; D003863:Depression / Q000188:drug therapy*; D013759:Dronabinol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007258:Informed Consent; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010919:Placebos; D011674:Pulse / Q000187:drug effects; D012649:Self Concept / Q000187:drug effects; D012890:Sleep / Q000187:drug effects
D010919:Placebos; D013759:Dronabinol